SecBot SecBot
PRESS-RELEASE ·Filed Aug 14, 2026

BCAX

Bicara Therapeutics Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

This is a routine inducement grant with no immediate trading signal. Monitor the FORTIFI-HN01 trial interim analysis in mid-2027 and any further leadership changes for material catalysts.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$24.28
T+0 close · Aug 14, 2026 · via day close
Latest settled
−58.90%
T+60 · $9.98
Vs SPY
−55.85%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 14 $24.28entry
  2. T+1 · 3mo ago +2.72%α +3.19% · $24.94
  3. T+5 · 3mo ago −1.57%α −0.20% · $23.90
  4. T+20 · 2mo ago −4.45%α −2.46% · $23.20
  5. T+60 · 8d ago −58.90%α −55.85% · $9.98

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Bicara Therapeutics announced an inducement stock option grant to new CFO Jennifer Larson, effective August 12, 2026, as a material inducement to her employment. The grant of 285,000 shares at $24.63 per share vests over four years and is routine compensation for a new executive. This filing confirms the CFO appointment previously signaled in the Q2 2026 earnings release and leadership transition.

Key Facts

  • Jennifer Larson appointed CFO effective August 12, 2026.
  • Received non-qualified stock option for 285,000 shares at $24.63 (closing price on grant date).
  • Vesting: 25% on first anniversary, then 12 equal quarterly installments.
  • Granted under 2026 Inducement Plan, approved by independent directors per Nasdaq Listing Rule 5635(c)(4).
  • Grant is outside stockholder-approved equity plans.

Financial Impact

Option grant of 285,000 shares at $24.63 exercise price; immaterial relative to $1.6B market cap.

dilution

Risk Factors

  • Execution risk from ongoing leadership transition (CEO stepping down Jan 2027, new CFO appointed).
  • No change to clinical or financial outlook from this filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
81% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3345313

Track record

26 reports on BCAX

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +5.65% at T+20 after the Apr 15, 2026 report. 1 of 3 went positive at some point.

Filters
  1. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $9.98 Now $9.75 −2.30% settles Dec 8
  2. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $8.89 Now $9.75 +9.67% settles Dec 3
  3. Nov 4, 202612d ago Press Release Neutral 2/10 Entry $8.89 Now $9.75 +9.67% settles Dec 3
  4. Oct 7, 20265w ago SC 13G/A Neutral 3/10 Entry $16.42 to $8.89 Now $9.75 −40.62% ▼ −45.86% −44.52% vs SPY
  5. Oct 5, 20266w ago Press Release Neutral 2/10 Entry $17.29 to $9.13 Now $9.75 −43.61% ▼ −47.19% −44.73% vs SPY
  6. Sep 22, 20267w ago Institutional Cluster Bullish 4/10 Entry $22.78 to $18.35 Now $9.75 −57.20% ▼ −19.45% −18.89% vs SPY
  7. Aug 25, 202611w ago 8-K Neutral 2/10 Entry $24.73 to $19.78 Now $9.75 −60.57% ▼ −20.02% −20.24% vs SPY
  8. Aug 14, 202613w ago Press Release Neutral 2/10 Viewing Entry $24.28 to $23.20 Now $9.75 −59.84% ▼ −4.45% −2.46% vs SPY
  9. Aug 12, 202613w ago Insider Cluster Neutral Not scored Entry $23.63 to $22.81 Now $9.75 −58.74% ▼ −3.47% −1.72% vs SPY
  10. Aug 12, 202613w ago Insider Cluster Neutral 4/10 Entry $23.63 to $22.81 Now $9.75 −58.74% ▼ −3.47% −1.72% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (11h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 14, 2026